Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy

被引:5
作者
Anguita, Rodrigo [1 ,2 ]
Desideri, Lorenzo ferro [2 ]
Schwember, Philipp [1 ,3 ]
Shah, Neil [1 ]
Ahmed, Syed [1 ]
Raharja, Antony [1 ]
Roth, Janice [1 ,2 ]
Sivaprasad, Sobha [1 ]
Wickham, Louisa [1 ]
机构
[1] Moorfields Eye Hosp NHS Fdn Trust, City Rd, London EC1V2PD, England
[2] Univ Hosp Bern, Inselspital, Dept Ophthalmol, Bern, Switzerland
[3] Sahlgrens Univ Hosp, Gothenburg, Sweden
关键词
PANRETINAL PHOTOCOAGULATION;
D O I
10.1016/j.ajo.2024.10.019
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To compare the clinical outcomes of early pars plana vitrectomy (PPV) versus delayed PPV in patients with first episode of vitreous hemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR). Design: Retrospective, comparative, interventional study. Subjects, participants, and/or controls: Consecutive patients with type 1 or II diabetes diagnosed with new onset VH secondary to PDR who underwent PPV at Moorfields Eye Hospital between December 2014 and December 2016. Exclusions were prior vitrectomy, iris neovascularization, neovascular glaucoma, macular edema, or presence of tractional/rhegmatogenous retinal detachment. Methods, intervention, or testing: Patients were divided into two groups based on the timing of their surgery: early PPV (<= 6 weeks) and delayed PPV (>6 weeks). Demographic and clinical features, including best-corrected visual acuity (BCVA), expressed in logMAR at baseline and 12 months were collected. Statistical analyses, including propensity score matching, were performed using Python 3.10, Scikit-learn, Pandas, and GraphPad Prism 10. Main outcome measures: BCVA at 12 months postoperatively, reoperation rates, and severity of complications. Results: A total of 178 eyes were analyzed (48 early PPV, 130 delayed PPV). The mean (SD) number of weeks before surgery was 3.36 (SD 1.6) for the early PPV group and 22.56 (SD 17.23) for the delayed PPV group (P < .0001). Baseline BCVA prior to PPV was similar between groups (P = .08). At 12 months, the early PPV group had significantly better BCVA (0.40 logMAR vs 0.67 logMAR; P = .02). Patients without evidence of posterior vitreous detachment on ultrasound or OCT showed more pronounced differences (0.3 logMAR vs 0.7 logMAR; P = .001). The early PPV group had fewer sight-threatening complications (P = .005). Multivariable logistic regression identified initial BCVA, early PPV, and absence of preoperative panretinal photocoagulation as significant predictors of better visual outcomes. Conclusions: Early PPV significantly improves visual outcomes and reduces severe complications in patients with VH secondary to PDR. These findings support the benefits of early surgical intervention to enhance long-term visual prognosis in these patients. However, a randomized clinical trial is warranted.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 19 条
[1]   Vitrectomy for vitreous haemorrhage due to proliferative diabetic retinopathy in eyes with mild visual impairment [J].
Anguita, Rodrigo ;
Shah, Neil ;
Wickam, Louisa .
EYE, 2024, 38 (18) :3403-3405
[2]   Could real-world data replace evidence from clinical trials in surgical retinal conditions? [J].
Anguita, Rodrigo ;
Charteris, David .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (08) :1037-1038
[3]  
[Anonymous], 1985, Arch Ophthalmol, V103, P1644
[4]  
[Anonymous], 1985, ARCH OPHTHALMOL-CHIC, V103, P1644
[5]   Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial [J].
Antoszyk, Andrew N. ;
Glassman, Adam R. ;
Beaulieu, Wesley T. ;
Jampol, Lee M. ;
Jhaveri, Chirag D. ;
Punjabi, Omar S. ;
Salehi-Had, Hani ;
Wells, John A., III ;
Maguire, Maureen G. ;
Stockdale, Cynthia R. ;
Martin, Daniel F. ;
Sun, Jennifer K. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (23) :2383-2395
[6]   VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy [J].
Arrigo, Alessandro ;
Aragona, Emanuela ;
Bandello, Francesco .
ANNALS OF MEDICINE, 2022, 54 (01) :1089-1111
[7]   Early pars plana vitrectomy for proliferative diabetic retinopathy: update and review of current literature [J].
Berrocal, Maria H. ;
Acaba-Berrocal, Luis .
CURRENT OPINION IN OPHTHALMOLOGY, 2021, 32 (03) :203-208
[8]   Panretinal Photocoagulation for Proliferative Diabetic Retinopathy [J].
Bressler, Neil M. ;
Beck, Roy W. ;
Ferris, Frederick L., III .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (16) :1520-1526
[9]  
El Annan Jaafar, 2014, Int Ophthalmol Clin, V54, P141, DOI 10.1097/IIO.0000000000000027
[10]   Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy A Secondary Analysis of a Randomized Clinical Trial [J].
Glassman, Adam R. ;
Beaulieu, Wesley T. ;
Maguire, Maureen G. ;
Antoszyk, Andrew N. ;
Chow, Clement C. ;
Elman, Michael J. ;
Jampol, Lee M. ;
Salehi-Had, Hani ;
Sun, Jennifer K. .
JAMA OPHTHALMOLOGY, 2021, 139 (07) :725-733